Atlas Trials

Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma

Clinical trial NCT01482520 · COMPLETED

Trial details

NCT number
NCT01482520
Sponsor
Samsung Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatocellular CarcinomaRenal Cell Carcinoma
Start date
2008-08-01
Primary completion
2013-09-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.